Bladder Recovery by Stem Cell Based Cell Therapy in the Bladder Dysfunction Induced by Spinal Cord Injury: Systematic Review and Meta-Analysis by Jae Heon Kim et al.
RESEARCH ARTICLE
Bladder Recovery by Stem Cell Based Cell
Therapy in the Bladder Dysfunction Induced
by Spinal Cord Injury: Systematic Review and
Meta-Analysis
Jae Heon Kim1, Sung Ryul Shim2, SeungWhan Doo1, Won Jae Yang1, ByungWook Yoo3,
Joyce Mary Kim4, Young Myoung Ko5, Eun Seop Song6, Ik Sung Lim7, Hong Jun Lee8*,
Yun Seob Song1*
1 Department of Urology, Soonchunyang University Hospital, Soonchunhyang University School of
Medicine, Seoul, Korea, 2 Institute for clinical molecular biology research, Soonchunyang University
Hospital, Soonchunhyang University School of Medicine, Seoul, Korea, 3 Department of Family Medicine,
Soonchunhyang University School of Medicine, Seoul, Korea, 4 International Clinic Center, Soonchunhyang
University Hospital, Seoul, Korea, 5 Department of Industrial and Management Engineering, Pohang
University of Science and Technology, Pohang, Korea, 6 Department of Obstetrics and Gynecology, Inha
University School of Medicine, Incheon, Korea, 7 Department of Industrial Management and Engineering,
Namseoul University College of Engineering, Cheonan, Korea, 8 Medical Research Institute, Chung-Ang
University College of Medicine, Seoul, Korea
* leehj71@gmail.com (HJL); yssong@schmc.ac.kr (YSS)
Abstract
Background
Bladder dysfunction induced by spinal cord injury (SCI) can become problematic and se-
verely impair the quality of life. Preclinical studies of spinal cord injury have largely focused
on the recovery of limb function while neglecting to investigate bladder recovery.
Objective
The present study was performed to investigate and review the effect of stem cell-based
cell therapy on bladder recovery in SCI.
Methods
We conducted a meta-analysis of urodynamic findings of experimental trials that included
studies of stem cell-based cell therapy in SCI. Relevant studies were searched using MED-
LINE, EMBASE and Cochrane Library (January 1990 - December 2012). Final inclusion
was determined by a urodynamic study involving detailed numerical values. Urodynamic
parameters for analysis included voiding pressure, residual urine, bladder capacity and
non-voiding contraction (NVC). Meta-analysis of the data, including findings from urody-
namic studies, was performed using the Mantel-Haenszel method.
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Results
A total of eight studies were included with a sample size of 224 subjects. The studies were
divided into different subgroups by different models of SCI. After a stem cell-based cell ther-
apy, voiding pressure (-6.35, p<0.00001, I2 = 77%), NVC (-3.58, p<0.00001, I2 = 82%), re-
sidual urine (-024, p = 0.004, I2 = 95%) showed overall significant improvement. Bladder
capacity showed improvement after treatment only in the transection type (-0.23, p =
0.0002, I2 = 0%).
Conclusion
After stem cell-based cell therapy in SCI, partial bladder recovery including improvement of
voiding pressure, NVC, and residual urine was demonstrated. Additional studies are need-
ed to confirm the detailed mechanism and to obtain an ideal treatment strategy for
bladder recovery.
Introduction
Worldwide, there are more than 130,000 new cases of traumatic spinal cord injury (SCI) annu-
ally, which is estimated to affect approximately 2.5 million people [1,2]. SCI affects people of
all ages and the present lack of curative treatments result in life-long functional impairments
that manifest as major physical disabilities [1]. Any recovery from functional loss that can
occur depends on the level, nature and severity of the injury [3]. Severe injuries yield very poor
outcomes and recovery is limited. Consequently, patients suffer from chronic paralysis and au-
tonomic dysfunctions in the body segments below the site of injury [3]. In addition, SCI leads
to disabling secondary complications, such as spasticity, bowel and bladder dysfunction, and
development of chronic neuropathic pain [4].
Among the secondary complications caused by SCI, patients suffer from urological compli-
cations [5] that include severe lower urinary tract dysfunctions including overactive bladder
and urinary retention, which result in increased bladder thickness and fibrosis [6,7]. The uri-
nary bladder wall accumulates connective tissue and becomes fibrotic following SCI, which
may adversely affect smooth muscle function and the micturition function resulting in a low
compliance bladder with low capacity and high threshold pressure.
Although the significance of a neurogenic bladder caused by SCI has been documented in
clinical studies associated with urinary tract infection and chronic renal failure [8], less focus
has been directed to preclinical SCI studies, especially stem cell-based cell therapy. Most SCI
studies with stem cell-based cell therapy have focused mainly on the motor limb function and
sensory recovery. Impaired quality of life (QoL) from loss of limb function likely exceeds that
of bladder dysfunction in the short term. However, in the long term, bladder dysfunction can
become problematic and impair severely QoL [9]. Despite these concerns and obstacles, re-
search on bladder recovery represents a promising area of research in neurourology. To date,
similar to preclinical research, clinical trials have focused mainly on the recovery of motor and
sensory function of limbs. Thus, limited evidence regarding bladder recovery exists [10,11].
In the present study, we investigated bladder recovery using stem cell-based cell therapy in
bladder dysfunction induced by SCI employing meta-analysis of urodynamic findings in pre-
clinical studies and highlighted the current status of stem cell-based cell therapy of bladder dys-
function in SCI with a systematic review.
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Materials and Methods
Study design
Ameta-analysis and systematic review were conducted according to predefined guidelines pro-
vided by the Cochrane Collaboration (2008).
Study selection
A comprehensive, multi-database electronic literature search was done to identify relevant re-
search articles published between December 1990 and December 2012 involving varied SCI
preclinical studies including stem cell-based cell therapy. The electronic search included the
PubMed, Embase and Cochrane Library databases without language restrictions. The Medical
Subject Headings (MeSH) and Emtree keywords included ‘‘spinal cord injuries”, “spinal inju-
ries”, ‘‘stem cells’,’ ‘‘cells, cultured”, “stem cell transplantation” and “Rat”.
The studies were included if the described experiments included spinal surgery; the de-
scribed interventions included administration of stem cell or other progenitor cells; the reported
outcomes included urodynamic findings like voiding pressure, residual urine, non-voiding con-
traction (NVC) and bladder capacity; and rats were the experimental animal. The articles were
excluded if the studies were unable to acquire full urodynamics data, involved non-randomized
controlled animal trial of low quality, or involved combined treatment with medications.
Data collection and analysis
The initial screening with electronic databases to identify potential studies for inclusion based
on title and abstract information was performed independently by two of the authors (Jae
Heon Kim and Sung Ryul Shim). In cases of insufficient data, both authors reviewed the full
text of the article for information and clarification. Final inclusion was determined by the se-
nior authors (Hong Jun Lee and Yun Seob Song). References and data for each included study
were carefully cross-checked to ensure no overlapping data was presented and to maintain the
meta-analysis integrity.
Assessment of methodological quality
The include studies assessed for risk of bias by the GRADEWorking Group and a managing
reviewer according to the Cochrane guidelines. The judgment of every item was low risk, un-
clear or high risk. Any disagreement regarding eligibility during the extraction was discussed
and resolved. Six assessed items were random sequence generation, allocation concealment,
blinding of outcome assessment, incomplete outcome data, selective reporting, and other bias.
Meta-analysis of urodynamic findings
Meta-analysis of the data including findings from urodynamic studies was performed using the
Mantel-Haenszel method with Review Manager software (RevMan version 5.0; Cochrane Col-
laboration, Germany) and Comprehensive Meta-Analysis version 2.2 software (Biostat, Engle-
wood, NJ, USA). All variables were continuous data, such as voiding pressure, residual urine,
NVC and bladder capacity. Mean ± standard deviation was used to calculate the weighted
mean difference (WMD) and 95% confidence interval (CI).
Assessment of heterogeneity
Statistical heterogeneity was assessed using the I2 value and the result of the chi-squared test. A
p<0.1 and I2>50% were considered suggestive of statistical heterogeneity, prompting a
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random effects modeling estimate. However, a non-significant chi-squared test result (p0.1
and I250%) indicated a lack of evidence for heterogeneity, but did not necessarily imply ho-
mogeneity, because there may have been insufficient power to detect heterogeneity.
Assessment of potential publication bias
Results of the comprehensive meta-analysis to examine any potential publication bias in the
studies are shown as Funnel plots.
Results
Inclusion of studies
The initial search identified 1708 articles from the electronic databases (929 from Embase, 775
from Pubmed, four from Cochrane). After exclusion of 362 studies containing overlapping
data or appearing in more than one database, and after screening the titles and abstracts, 918
studies that did not meet the inclusion criteria were further excluded. After intensive screening
for detailed evaluation of the remaining 428 studies, 10 studies were eligible. Of these, two were
excluded due to lack of specific urodynamic study information. Finally, eight studies that
met all inclusion criteria were included. The eight studies consisted of 222subjects (110 experi-
mental and 112 controls). A detailed flow chart for selection is shown in Fig. 1. A systematic re-
view of the 10 studies was conducted on the detailed experimental differences and expected
mechanisms (Tables 1 and 2). In five studies [12–16], two different treatment subgroups were
included. Therefore, the meta-analysis comprised a total of 13 trials (Table 3).
Risk of bias in the included studies
A summary of methodological domain assessment for each subject is detailed in Table 1. Only
two studies demonstrated the possibility of bias in blinding of outcome assessment.
Fig 1. Method for study search and selection for inclusion.
doi:10.1371/journal.pone.0113491.g001
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Table 1. Details of studies investigating stem cell-based cell therapy in spinal cord injury and bladder dysfunction.
Author Injured
level
Injury
mechanism
Admitted cell Route Remarks Expected mechanism Graft survival
conﬁrmation
Hu, 2012
[17]
T8–9 Transection BMSC, Bone
marrow
stromal cell
Intravenous External urethral
sphincter activity was
checked, Cooridnation
between bladder
activity and EUS was
checked
No sparing of
descending modulatory
pathway.
Reorganization of
synaptic connections.
Formation of new
pathways of voiding
reﬂex
Immunohistochemistry of
BrdU reactive cell
Jin, 2011
[12]
T9–10 Contusion GRP, GDA Direct
injection
Daily records of
bladder size and urine
color, Human GRP
and GDA did not
promote axon growth
Neuroprotection, axonal
sprouting, regeneration
or myelination
HuNA (+)
Immunoﬂuorescence
Park, 2010
[15]
T8–9 Contusion Human MSC Direct
injection
BDNF and NT-3 levels
were checked by
ELISA and RT-PCR at
28 and 56 days after
MSC transplantation.
No bladder recovery
Transplanted MSCs
could reduce
inﬂammatory process
Immunohistochemistry of
anti-human nucleus
antibody
Mitsui,
2011 [13]
T8–9 Contusion NRP/GRP,
AMPA/kinase
blocker
(NBQX)
Direct
injection
Combined treatment
using NRP/GRP and
NBQX
Combined treatment
have a potential of
protection of host tissue
and reduction of
secondary injury
Not checked
Erdogan,
2013[43]
T8–9 Transection,
incomplete
Human
umbilical cord
MSC
Direct
injection
Masson trichome stain
used to demonstrate
bladder morphology
Bladder structure
change by reducing
inﬂammation. Lamina
propia layer change
demonstrates reduced
inﬂammation
Not checked
Telmeltas,
2009[16]
T9–10 Hemisection NRP/GRP,
BMSC
Direct
injection
Camparison of
transplantation using
NRP/GRP and BMSC
Neurogenesis by the
capacity to grow new
neurons from neural
stem/progenitor cells
Direct count of cells
Mitsui.
2005 [18]
T8–9 Contusion Fb-BDNF, Fb-
NT3
Direct
injection
Genetically modiﬁed
ﬁbroblast
Partial bladder recovery
is mediated by the
greater density of some
descending ﬁbers and
decreased density of
small caliber primary
afferent projections by
BDNF or NT3. Tissue
sparing throughout the
white matter and
differentiation into
neurons and glia
Direct cell conﬁrmation by
Nissl myelin staining.
mmunoreactivity for RT-
97
Neuhuber,
2008 [44]
T8–9 Contusion NPC, Neural
progenitor cell
Direct
injection or
lumbar
puncture
graft
Different route and
method were
compared. Direct
injection vs lumbar
puncture graft. Lumbar
puncture graft showed
localization at the
dorsal aspect rather
than entire injury site,
which results in partial
recovery of motor
function
Direct cell conﬁrmation by
Nissl myelin staining.
Alkaline phosphatase
histochemistry
Mitsui,
2005 [14]
T8–9 Contusion NRP/GRP Direct
injection
Examined the alpha-
1A adrenergic
antagonist effects.
Tamsulosin showed
positive effect in
voiding pressure
Local protection
provided by NRP/GRP
results in increased
sparing/sprouting of
descending pathways.
Modiﬁcation of
lumbosacral circuitry
Direct cell conﬁrmation by
Nissl myelin staining.
Alkaline phosphatase
histochemistry
(Continued)
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Table 1. (Continued)
Author Injured
level
Injury
mechanism
Admitted cell Route Remarks Expected mechanism Graft survival
conﬁrmation
Mitsui,
2003 [19]
T8–9 Contusion EG6
immortalized
neural stem
cell
Direct
injection
Observed difference in
the degree of
functional recovery
between detrusor and
external urethral
sphincter: Functional
recovery of somatic
nerves is more easily
accomplished by
transplanted EG6 cells
Transplanted EG6 cells
might differentiate and
promote regeneration of
injured spinal cord
Conﬁrmation with BrdU
immunohistochemistry
GRP, glial-restricted precursor; GDA, derived astrocytes; MSC, mesenchymal stem cell; BDNF: brain derived neurotrophic factor; NRP, neuronal-
restricted precursor; NBQX, 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline; BMSC, bone marrow stromal cell; NT-3,neurotrophin-3; Fb, ﬁbroblast;
NPC
doi:10.1371/journal.pone.0113491.t001
Table 2. Study details including defensemechanisms, stability and plasticity of stem cells in stem cell-based cell therapy for SCI and bladder
dysfunction.
Author Migration Host effects:
spared host
tissue, cyst and
scar formation
Plasticity or projections Differentiation Functional
recovery
Sensory recovery
Hu 2012
[17]
Yes Not checked L3–4 Not checked Not checked Not checked
Jin, 2011
[12]
Yes, long
distance
Reduced cyst and
scar formation.
Reduced CSPG
expression.
Reduced glial
scar formation
L6-S1, GRP Group showed
reduced CGRP sprouting,
GDA group showed higher
5-HT immunoreactivity
Differentiated into glial
cells
No signiﬁcant
recovery in BBB
test and grid test
Pain perception
improved Thermal
sensitivity (heat
test). Mechanical
sensitivity (Von
Frey test)
Park, 2010
[15]
No checked Not checked BDNF and NT-3 levels
showed no difference at
thoracic and lumbar
vertebrae L5-S1
Not differentiated Limited recovery
in chronic state in
BBB test,
coupling score,
and ladder score
Not checked
Mitsui,
2011[13]
No checked Reduced cyst and
cavity formation
5HT positive ﬁbers showed
higher density in both DL
and DH. CGRP positive
ﬁbers in small diameter
dorsal root afferents
Not checked Recovery in BBB
test
Not checked
Erdogan,
2013[43]
Not checked Not checked Not checked Not checked Not checked Not checked
Telmeltas,
2009 [16]
Not checked Not checked T9–10, E-NCAM (+), A2B5
(+)
Neuronal
differentiation
Not checked Not checked
Mitsui.
2005 [18]
Conﬁrmed by
Nissl-myelin
staining
No difference in
astrocytic scar
formation
L6-S1, Afferent pathways
using CGRP and VR-1.
Suppression in transplanted
group. No change in
synaptic density.
Descending pathways using
5HT, CRF, DβH. Postive for
markers for neurons (MAP-
2). Partially preserved or
stimulated sprouting. No
axonal growth by GAP-43
Partially neuronal
regeneration. No
axonal growth
No signiﬁcant
recovery in BBB
test and recovery
in grid test
No change in
thermal sensitivity
test
(Continued)
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These studies did not include the sham model. Overall, the risk of bias was considered to be
low (Fig. 2).
Urodynamic findings
Detailed findings of the urodynamic studies are described in Table 3. Voiding pressure (11 tri-
als), residual urine (9 trials), bladder capacity (10 trials) and NVC (8 trials) were analyzed.
Study trials examining bladder weight, baseline pressure, voiding frequency and voiding effi-
ciency were too small for analysis, and therefore those variables were excluded.
A total of 11 trials (n = 187; 94 experimental and 93 controls)[12–19] reported detailed data
on voiding pressure. The WMD change of voiding pressure improvement from baseline was
-6.35 (95% CI; -8.22, -4.48) (p<0.00001) (Fig. 3). Heterogeneity test showed p<0.00001 and
Higgins’ I2 was 77%. Test of subgroup differences showed p = 0.18 and Higgins’ I2 was 43.6%.
A total of 9 trials in seven studies (n = 152; 79 experimental and 73 controls)[12–14,16–19]
reported detailed data on residual urine. The WMD change of residual urine improvement
from baseline was -0.24 (95% CI; -0.40, -0.07)(p = 0.004)(Fig. 4). Heterogeneity test showed
p<0.00001 and Higgins’ I2 was 95%. Test of subgroup differences showed p<0.00001 and
Higgins’ I2 was 98.9%. In transection model, residual urine showed significant improvement
that the WMD change of residual urine in transection model was -0.88 (95% CI; -1.03, -0.73)
(p<0.00001) (Fig. 4).
A total of 8 trials in six studies (n = 140; 72 experimental and 68 controls) [12–14,16–18] re-
ported detailed data on NVC. The WMD change of NVC improvement from baseline was
-3.58 (95% CI; -4.87, -2.29) (p<0.00001) (Fig. 5). Heterogeneity test showed p<0.00001 and
Table 2. (Continued)
Author Migration Host effects:
spared host
tissue, cyst and
scar formation
Plasticity or projections Differentiation Functional
recovery
Sensory recovery
Neuhuber,
2008 [44]
Some graft
derived glial cells
migrated away
from the graft
tissues Conﬁrmed
by Nissl myelin
staining
Both group
showed reduction
in injury size and
tissue sparing
L4–5, Oligodendrocytes
(RIP) and astrocytes
(GFAP)
Presence of neuronal
and glial phenotypes.
Neuronal
differentiation
Intermediate
recovery in BBB
test
Not checked
Mitsui,
2005 [14]
Conﬁrmed by
Nissl myelin
staining
Spared host
tissue and cyst
developed fewer
L6-S1, Afferent pathways:
no differences in CGRP,
VR-1, GAP43.
Synaptophysin projections.
NRP/GRP transplants inhibit
dorsal root sprouting: CRF
and DβH were diminished
but lesser extent in
transplant group. Sprouting
or sparing of these
pathways.
Neuronal
differentiation Axonal
neuroﬁlaments with
RT 97 antibody
astrocyte
differentiation with
GFAP
Greater recovery
of hindlimb
function but
similar results in
grid test
Improvement in the
thermal stimulus
Mitsui,
2003[19]
BrdU, Migration
into white matter
Not checked Not checked Not checked Not checked Not checked
CSPG, Chondroitin sulfate proteoglycan;, neuronal-restricted precursor; VR-1,vanilloid receptor type 1; CGRP, calcitonin gene-related peptide; DL,
Dorsolateral nucleus; DH, Dorsal horn; BBB, Basso, Beattie, Bresnahan; 5-HT, serotonin; DβH, dopamine-β-hydroxylase; CRF, corticotropin releasing
factor; GFAP, glial ﬁbrillary acidic protein; GRP, glial-restricted precursor; GAP43, growth-associated protein 43
doi:10.1371/journal.pone.0113491.t002
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Table 3. Urodynamic study results of the eight enrolled studies.
Author Admitted
time
Cystometry time Cystometric ﬁndings Sham Control Transplanted group
Hu 2012 [17] 9 days after
injury
28 days after
transplantation
N = 6 N = 8 N = 8
Voiding pressure 26.35±4.18 40.74±3.97 33.82±3.79*
Residual urine (ml) 0.1±0.08 1.53±0.68 0.89±0.17*
Bladder capacity (ml) 0.35±0.14 1.57±0.68 1.20±0.22
Voiding efﬁciency (%) 70.38±10.10 2.78±1.46 26.25±6.93*
NVC 0 9.67±3.83 2.13±1.13*
Jin, 2011 [12] 9 days after
injury
8 weeks after
transplantation
N = 4 N = 10 N = 9, Transplanted CRP
Voiding pressure 15.58±2.58 42.32±4.07 36.21±1.72
Residual urine 0±0 0.12±0.08 0.42±0.13
Bladder capacity 0.33±0.03 0.60±0.20 1.04±0.10*
NVC 0.25±0.15 16.36±5.57 6.25±0.79*
Bladder weight: body
weight ratio (g)
0.61±0.02 1.3±0.07 1.43±0.09
N = 4 N = 10 N = 6, Transplanted GDA
Voiding pressure 15.58±2.58 42.32±4.07 37.21±2.04
Residual urine 0±0 0.12±0.08 0.13±0.08
Bladder capacity 0.33±0.03 0.60±0.20 0.53±0.05
NVC 0.25±0.15 16.36±5.57 19.25±1.70
Bladder weight: body
weight ratio (g)
0.61±0.02 1.3±0.07 1.38±0.08
Park, 2010 [15] 9 days after
injury
28 days and 56 days N = 7 N = 11 N = 9, Transplanted (28
days)
Voiding pressure 9.21±5.30 9.60±4.2 9.70±4.11
NVC (%) 43 36 44
Voiding frequency (time/
min)
0.80±0.09 0.82±0.16 0.76±0.32
Bladder volume (mm3) 1345.25
±1206.27
1263.75
±838.05
1279.57±1310.69
N = 7 N = 9 N = 6, Transplanted (56
days)
Voiding pressure 9.00±5.77 8.11±7.39 10.33±4.50
NVC (%) 43 44 50
Voiding frequency (time/
min)
0.79±0.11 0.82±0.19 0.92±0.07
Bladder volume (mm3) 1874.47
±1452.13
1925.99
±1591.44
1594.45±703.36
Mitsui, 2011 [13] 9 days after
injury
7 weeks after
transplantation
N = 9 N = 10, Transplanted
(NRP/GRP)
Voiding pressure 36.1±2.7 27.9±2.0*
Residual urine 0.16±0.04 0.14±0.08
Bladder capacity 1.54±0.06 1.53±0.17
NVC 7.0±1.0 3.4±0.9*
Bladder weight (mg) 368.3±35.0 289.6±19.6*
(Continued)
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Higgins’ I2 was 82%. Test of subgroup differences showed p = 0.89 and Higgins’ I2 was 0%. In
contusion model, residual urine showed significant improvement that the WMD change of
NVC was -3.68 (95% CI; -5.09, -2.27) (p<0.00001) (Fig. 5).
A total of 10 trials in seven studies (n = 175; 87 experimental and 88 controls) [12–18] re-
ported detailed data on bladder capacity. Overall mean difference showed -0.04 (95% CI;-0.18,
0.10) (p = 0.58) (Fig. 6). Bladder capacity showed different results according to SCI types.
Table 3. (Continued)
Author Admitted
time
Cystometry time Cystometric ﬁndings Sham Control Transplanted group
Telmeltas, 2009
[16]
9 days after
injury
28 days after
transplantation
N = 5 N = 5 N = 10, Transplanted
(NRP/GRP)
Voiding pressure 24.90±4.03 61.80±9.41 43.40±5.71*
Residual volume 0.05±0.07 1.61±0.23 0.64±0.12*
Bladder capacity 0.57±0.13 1.89±0.18 1.64±0.13*
NVC 0.20±0.44 5.80±2.58 4.10±1.91*
Baseline pressure 2.15±0.54 8.78±0.55 3.38±0.30*
Voiding volume 0.56±0.12 0.27±0.05 1.02±0.08*
N = 5 N = 5 N = 9, Transplanted
(BMSC)
Voiding pressure 24.90±4.03 61.80±9.41 53.10±7.88*
Residual volume 0.05±0.07 1.61±0.23 0.79±0.20*
Bladder capacity 0.57±0.13 1.89±0.18 1.70±0.10*
NVC 0.20±0.44 5.80±2.58 4.90±2.60*
Baseline pressure 2.15±0.54 8.78±0.55 5.16±1.03*
Voiding volume 0.56±0.12 0.27±0.05 0.90±0.18*
Mitsui. 2005 [18] 9 days after
injury
8 weeks after
transplantation
N = 6 N = 11 N = 12
Voiding pressure 19.5±1.0 35.9±1.4 28.2±0.9*
Residual volume 0.03±0.01 0.24±0.03 0.23±0.09
Bladder capacity 0.44±0.06 1.07±0.09 1.12±0.12*
NVC 0 6.7±1.0 3.2±0.8*
Bladder weight 119.3±6.7 376.8±31.7 279.8±17.8*
Mitsui, 2005 [14] 9 days after
injury
8 weeks after
transplantation
N = 6 N = 10 N = 8
Voiding pressure 19.5±1.0 33.4±1.2 27.9±2.0*
Residual volume 0.03±0.01 0.24±0.05 0.14±0.08
Bladder capacity 0.44±0.06 1.66±0.19 1.53±0.17
NVC 0 7.2±1.0 3.4±0.9*
Bladder weight 119.3±6.7 376.8±33.4 289.6±19.6*
Mitsui, 2003 [19] 9 days after
injury
28 days after
transplantation
N = 5 N = 7
Voiding pressure 39.0±7.4 23.2±4.2*
Residual volume 3.14±1.84 0.94±0.75*
Voiding volume 0.94±0.30 1.13±0.22
Voiding efﬁciency (%) 27.9±16.6 60.7±19.8*
NVC (%) 60 57
NVC, non-voiding contraction (No. of episodes/micturition);NRP, neuronal-restricted precursor; GRP, glial-restricted precursor; NBQX, 2,3-dihydroxy-
6-nitro-7-sulfamoyl-benzo(f)quinoxaline
*:p<0.05, transplanted group vs. control
doi:10.1371/journal.pone.0113491.t003
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Although contusion model showed no significant improvement after treatment (p = 0.55),
transection model showed significant improvement after treatment (p = 0.0002) (Fig. 6).
Publication bias
Funnel plot analysis of 11 studies reporting voiding pressure is summarized in Fig. 7. Two stud-
ies positioned left of the funnel and two studies lie to the right. Begg and Mazumdar’s
Fig 2. Risk of bias summary. A review of the author’s judgments about each risk of bias item for each
included study. “+”is “low risk”, “-“is “high risk”, “?” is “unclear”.
doi:10.1371/journal.pone.0113491.g002
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Fig 3. Forest plot diagram showing the effect of stem cell-based cell transplantation on voiding pressure. The black diamond signifies the mean
difference is in favor of voiding pressure. The size of each square depends on the weight of each study. All data provided are for continuous outcomes.
doi:10.1371/journal.pone.0113491.g003
Fig 4. Forest plot diagram showing the effect of stem cell-based cell transplantation on residual urine. The black diamond signifies that the mean
difference is in residual urine. The size of each square depends on the weight of each study. All data provided are for continuous outcomes.
doi:10.1371/journal.pone.0113491.g004
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Fig 5. Forest plot diagram showing the effect of stem cell-based cell transplantation on non-voiding contraction (NVC). The black diamond signifies
the mean difference is in favor of NVC. The size of each square depends on the weight of each study. All data provided are for continuous outcomes.
doi:10.1371/journal.pone.0113491.g005
Fig 6. Forest plot diagram showing the effect of stem cell-based cell transplantation on bladder capacity. The black diamond signifies the mean
difference is in favor of bladder capacity. The size of each square depends on the weight of each study. All data provided are for continuous outcomes.
doi:10.1371/journal.pone.0113491.g006
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correlation was -0.091 (two-tailed p = 0.697). Egger’s regression intercept was -0.230 (two-
tailed p = 0.842). Thus, there was no evidence of publication bias in this meta-analysis.
Discussion
The use of neuroregeneration in stem cell-based cell therapy to correct bladder dysfunction is a
logical and promising strategy. Spinobulbospinal pathways regulate and coordinate micturition
reflexes. These pathways are located predominately in the dorsal and lateral columns of the spi-
nal cord [20,21]. The contusion injury model, which is the most common SCI model, features
the preferential destruction of the dorsal region of the spinal cord. This region is also destroyed
in the transection model because injury to this region is necessary to study the spinal cord. The
rat model of bladder dysfunction caused by SCI resembles the human condition [6,22,23].
Although complete recovery from SCI is impossible, several studies have demonstrated
some functional recovery including limb function and sensory function. To date, very few stud-
ies have demonstrated bladder recovery utilizing urodynamic studies including cystometry
(Table 3). This is the first study in which a detailed meta-analysis of urodynamic findings rele-
vant to bladder function has been done.
Among the limitations of our study, the most important one is the several heterogeneities
including types of SCI models and cell types (Tables 1–3). To control this heterogeneity, sub-
analysis regarding the type of SCI model (contusion vs. transection) was done. Concerning the
cell types, we did not analyze the subgroup analysis because the nature of the cells was similar
and they shared the property of capability of regeneration into neuronal cells. Concerning the
transplantation route, all studies adapted direct transplantation into the injured site except for
one's study which had adopted the intravenous route. We did not conduct a subgroup analysis
for this issue because of the small number of available studies and considering the homing and
migration activity of stem cells.
Despite these heterogeneities, the timing of cell transplantation was the same (9 days after
SCI), as was the timing of assessment of urodynamics (at least after 28 days following cell trans-
plantation). Moreover, the injured site was similar with the thoracic vertebrae.
Fig 7. Funnel plot with peusdo 95% confidence limit.
doi:10.1371/journal.pone.0113491.g007
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SCI weakens voluntary bladder and external urethral sphincter control in rats [21]. The
main pathological micturition mechanism for bladder dysfunction following SCI is continuous
co-contractions of the bladder and the sphincter leading to inefficient voiding and large residu-
al urine volumes [24]. Continuous high bladder pressure and urine retention in SCI rats leds to
complete deterioration of bladder compliance, function, infection and other lower urinary tract
complications [25]. Augmented collagen deposition is considered to be an indicator of reduced
bladder compliance, consistent with reports of experimental animal models with SCI [20,26].
SCI rats also exhibited frequent urination [7].
Presently, there was a significant improvement of voiding pressure after stem cell-based cell
transplantation in the both contusion and transaction models (Figs. 3). Residual urine and
bladder capacity improved after treatment only in the transection model, and NVC improved
after treatment only in the contusion model (Figs. 4–6).
Improved incidence of NVC during bladder filling has been described in all but two studies
[15,19]. The main mechanism for this is that transplanted stem cells inhibit unmediated C-
fiber sprouting from bladder afferents, which decreases the C-fiber bladder-to-bladder spinal
micturition reflex in SCI rats [18,19].
It is logical to ascribe the late recovery to the parasympathetic system than somatic pathway
system. Temeltas et al. [16] reported this issue in their recent study on transplantation of neu-
ronal-glial restricted precursors or neural cells to rats with traumatic SCI [8], suggesting that
recovery of function mediated by parasympathetic systems may be more difficult to accomplish
than function mediated by somatic pathways [19].
The recovery of a micturition reflex is demonstrating by the descending projections, which
diminish sprouting by C-fibers and by the provision of greater descending control over sensory
transmission in the NVC [22,23,27,28]. Mitsui et al. [14] reported that the sprouting of primary
afferents contributes to bladder dysfunction, specifically NVC, but the more nearly normal
immunoreactivity can account for the diminished NVC in neural restricted precursor (NRP)/
glial restricted precursor (GRP) rats.
Significant improvements were observed in voiding pressure and residual urine during mic-
turition, which were attributable to alleviating sphincteric dysfunctions. The improvement of
NVC and voiding pressure is due to the amelioration of dyssynergia between the bladder and
urethral sphincter [19,29]. Attributable improvements in the neuronal circuitry include the
central nervous system and the normalization of bladder tone. However, there was no decrease
in the bladder capacity in most studies, compared with controls. Such an increase in the blad-
der capacity is thought to be caused by bladder over-distention during the reflex period by SCI
itself [30]. The main mechanism of recovery of voiding function in the two different types of
SCI is different. In the contusion model, the main mechanism involves the promotion of partial
sparing of descending modulatory pathways that course through the lateral and ventral funiculi
to the lumbosacral cord [14,18]. Spinal cord contusion interrupts axons from both ascending
and descending tracts. A recent study demonstrated the effects of cell transplantation on gener-
al axon growth using neurofilament staining, and on regeneration of the afferent axons and de-
scending serotonergic axons [31]. Voiding pressures were lower after transplantation of NRP/
GRP, which indicates the amelioration of dyssynergia between the bladder and urethral sphinc-
ter [14,18,19,32]. In the transection model, the main mechanism is the reorganization of synap-
tic connections in dorsal gray commissure of L3–4, which is responsible for the genesis of the
new voiding reflex pathways in SCI rats. Marson [33] and Lee et al. [34] found that neurons in
the dorsal gray commissure activated by pudendal or pelvic nerve stimulation might integrate
afferent signal neurons within multiple spinal segments.
Cell transplantation for the treatment of SCI has been studied extensively over the last two
decades. A wide variety of stem cell-based cell types have been used based on their potential to
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regenerate myelin, promote and guide axonal growth, bridge the site of injury or differentiate
into neuronal or glial cells. Lepore et al. reported that NRP/GRP cells remain viable in the in-
jured spinal cord, migrate outside of the injured region, differentiate into mature central ner-
vous system phenotypes and support neuronal development [35].
Preclinical SCI studies have used neural stem cell/progenitor cells (NSCs/NPCs), umbilical
cord blood derived cells, mesenchymal stem cells (MSCs), induced pluripotent cells (iPSCs),
Schwann cells and olfactory ensheathing cells. Our enrolled studies measuring bladder dys-
function used NSCs/NPCs [12–14,16,18], MSCs or bone marrow stromal cells [15,17] and em-
bryonic NSCs [19] (Table 1).
In the adult mammalian central nervous system, the genesis of new neurons has been docu-
mented, specifically in the subgranular layer of the dentate gyrus of the hippocampus and the
subventricular zone (SVZ) of the lateral ventricles [36]. In these regions, adult NPCs self-renew
and become multipotent after in vitro transplantation into the central nervous system [37,38].
Despite significant advances in transplantation using NPCs, several disadvantages remain.
These include inefficient tracking systems and moderate cell survival [39]. In addition, axonal
regeneration by endogenous or exogenous NSCs may contribute to the formation of a glial scar
[40]. Nonetheless, adult NSCs represent a safe, non-tumorigenic source of trophic support that
may have merit for clinical application. Despite an absence of evidence of differentiation into
neuronal cell types, several experimental studies have resulted in functional recovery in ani-
mals, supporting their potential use in cell therapy in SCI.
Among the enrolled studies, five used NPCs including neural restricted precursors, glial re-
stricted precursors, human glial restricted progenitors, derived astrocytes and transgenically
modified fibroblasts [18]. In SCI experimental models, MSCs were used less than NPCs, and
MSCs were better in bladder outlet models. The main reason for this tendency is that NSCs/
NPCs are considered more trophic and produce more favorable outcomes of neuronal regener-
ation after direct stem cell transplantation into the injured site.
MSCs were the first type of stem cells used to treat patients and, until recently, were the
only stem cell type whose safety had been established [2]. Moreover, MSCs can transdiffer-
entiate into neurons and glial cells [41], and can act in the physical guidance of neurofila-
ment outgrowth in SCI [42]. However, among the enrolled studies, only two included
human MSCs and two included bone marrow stromal cells [15,17] (Table 1). To date,
most clinical trials of SCI have involved MSC-based cell therapy because of their relative
ease of acquisition and safety [10]. To date, the role of MSCs in SCI is limited to the reduc-
tion of the inflammatory process within the injured spinal cord. Park et al. [15] could not
demonstrate direct neuronal regeneration after transplantation of MSCs. However, clinical
trials have shown limited bladder recovery using simple questionnaires and none included
urodynamic studies.
Limitations in our study included heterogeneity. Lack of reproducibility resulting partly
from differences in SCI models and treatment methods is the most critical issue. To date, no
standard tool has been developed to check study quality, which makes meta-analysis of experi-
mental research difficult.
Conclusions
The present meta-analysis and systematic review regarding bladder recovery after stem
cell-based cell therapy in SCI demonstrates significant improvements in voiding pressure,
residual urine and NVC. Considering the large volume of research on stem cell therapy in
SCI preclinical studies, additional studies are necessary for improved understanding of
bladder recovery.
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